ProDigest is a dynamic pre-clinical CRO at the forefront of in vitro and ex vivo simulation of the gastrointestinal tract and its microbiome, supporting innovation across the (functional) food, feed, and pharmaceutical industries.
With nearly two decades of experience, ProDigest brings together best-in-class technology platforms, a wide array of advanced analytical capabilities, and deep scientific expertise to guide product development from early discovery all the way to final stages. The company supports a broad range of applications, including functional foods and ingredients, pre-, pro-, syn- and postbiotics, nutraceuticals, as well as live biotherapeutic products (LBPs), biologicals, APIs, and complete formulations.
What truly sets ProDigest apart is its tailored approach. With the widest portfolio of gut models, each project is built around the client’s specific research question—ensuring the most relevant model is selected, rather than applying a one-size-fits-all solution. This enables clients to uncover health benefits early on, gain valuable insights into mechanisms of action and interindividual variability, and confidently de-risk their product development—all within an animal-free research framework.
Driven by a passionate team, a strong culture of innovation, and a commitment to customer success, ProDigest delivers flexible, high-quality, and scientifically robust solutions designed to move your product forward.
| Sales markets | Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Primary business activity | Food Safety, Quality and Service |
| Affiliated categories: | Other Microorganisms & Probiotics |Functional food |Nutricosmetics More |